Welcome to JEmedis

JEmedis is competence and service.

Whether as a CDMO or as an expert company in the fields of urology and oncology — JEmedis stands for uncompromising quality and first-class service.

JEmedis as cdmo

Contract manufacturing at JEmedis

Whether for process development, analysis or the manufacture of your product — JEmedis is your reliable and competent CDMO.

Urological and oncological expertise

Our product for the treatment of bladder cancer

Doxorubicin, the active ingredient in our drug, is the first cytostatic drug developed for the prevention of recurrence in superficial bladder cancer. JEmedis offers an exclusive bladder instillation set. JEmedis is also developing another product for this therapeutic area.

You are interested in

for CDMO

(contract manufacturing)?

Click here

You are interested in 

our products in the area of

the Urology/Oncology?

Click here

JEmedis GmbH is a pharmaceutical
company, emerged from
PharmaCept GmbH, which focuses on two
areas:

  • Distribution and development of pharmaceuticals and other products in the field of urology / oncology

  • as CDMO, in terms of process development and contract manufacturing of biologics

Find out more about the JEmedis team, our mission and the history of our company.

Find out more about our proven medicine for the prevention of bladder cancer recurrence.

Find out more about how JEmedis can support you in your product development. 

You want to get to know JEmedis better. We look forward to hearing from you and will get back to you as soon as possible.

JEmedis is a young pharmaceutical company, emerged from PharmaCept GmbH, which I founded. JEmedis stands for a committed team with short decision-making paths, so that processes can be implemented quickly and easily. We combine innovative know-how with many years of experience.

Dr. Jürgen Ebert

Founder and Managing Director of JEmedis
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.